NCT00358540View on ClinicalTrials.gov

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 1, 2006

Primary Completion Date

October 22, 2010

Study Completion Date

October 22, 2010

Conditions
Thrombocytopaenia
Interventions
DRUG

eltrombopag

Dosing of sarcoma subjects with eltrombopag after treatment with Adriamycin and Ifosfamide.

Trial Locations (7)

19106

GSK Investigational Site, Philadelphia

29605

GSK Investigational Site, Greenville

33136

GSK Investigational Site, Miami

33612

GSK Investigational Site, Tampa

75246

GSK Investigational Site, Dallas

90403

GSK Investigational Site, Santa Monica

77030-4009

GSK Investigational Site, Houston

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY